15 insiders reported 65 Form 4 transactions for Pacira BioSciences, Inc. (PCRX) over the past 18 months (most recent 2026-08-18). Recent activity: SLONIN JONATHAN (Chief Medical Officer) Sell 3,040 shares, CHRISTIE CHRISTOPHER (Director) Buy 6,405 shares, Froimson Mark (Director) Buy 6,405 shares, Young Alethia (Director) Buy 6,405 shares, Brege Laura (Director) Buy 6,405 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | SLONIN JONATHAN | Chief Medical Officer | Sell | 3,040 | $70,619 |
| 2026-06-12 | CHRISTIE CHRISTOPHER | Director | Buy | 6,405 | $0 |
| 2026-06-12 | Froimson Mark | Director | Buy | 6,405 | $0 |
| 2026-06-12 | Young Alethia | Director | Buy | 6,405 | $0 |
| 2026-06-12 | Brege Laura | Director | Buy | 6,405 | $0 |
| 2026-06-12 | YANG MICHAEL J. | Director | Buy | 6,405 | $0 |
| 2026-06-12 | RIKER LAUREN | Senior Vice President, Finance | Sell | 6,115 | $143,702 |
| 2026-06-12 | BIGAL MARCELO | Director | Buy | 6,405 | $0 |
| 2026-06-12 | Hirawat Samit | Director | Buy | 6,405 | $0 |
| 2026-06-05 | RIKER LAUREN | Senior Vice President, Finance | Sell | 3,187 | $71,134 |
| 2026-06-05 | SLONIN JONATHAN | Chief Medical Officer | Sell | 4,728 | $105,529 |
| 2026-06-05 | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 8,528 | $190,345 |
| 2026-06-05 | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 10,259 | $228,468 |
| 2026-04-24 | Cross Shawn | Chief Financial Officer | Buy | 12,941 | $212,879 |
| 2026-04-24 | Cross Shawn | Chief Financial Officer | Sell | 12,941 | $325,596 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Buy | 7,714 | $126,895 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Sell | 7,714 | $193,930 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Buy | 2,845 | $46,800 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Sell | 2,845 | $71,153 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Buy | 1,500 | $24,675 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Sell | 1,500 | $37,515 |
| 2026-03-19 | Kronenfeld Mark A. | Director | Buy | 6,163 | $0 |
| 2026-03-19 | Froimson Mark | Director | Sell | 500 | $10,905 |
| 2026-03-19 | SLONIN JONATHAN | Chief Medical Officer | Sell | 3,261 | $74,416 |
| 2026-02-13 | Teehan Brendan | Chief Commercial Officer | Buy | 51,714 | $0 |
Source: SEC Form 4 filings · as of 2026-08-18